Franklin Resources’s ProQR Therapeutics PRQR Stock Holding History

Franklin Resources’s Portfolio PRQR Stock Details PRQR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-309,700	Closed	-$952K	–	1520
2018 Q1	$952K	Hold	309,700	–	–	﹤0.01%	1300
2017 Q4	$999K	Hold	309,700	–	–	﹤0.01%	1317
2017 Q3	$1.5M	Hold	309,700	–	–	﹤0.01%	1251
2017 Q2	$1.61M	Hold	309,700	–	–	﹤0.01%	1261
2017 Q1	$1.55M	Hold	309,700	–	–	﹤0.01%	1280
2016 Q4	$1.52M	Hold	309,700	–	–	﹤0.01%	1271
2016 Q3	$2.07M	Hold	309,700	–	–	﹤0.01%	1244
2016 Q2	$1.5M	Hold	309,700	–	–	﹤0.01%	1287
2016 Q1	$1.51M	Hold	309,700	–	–	﹤0.01%	1279
2015 Q4	$2.69M	Hold	309,700	–	–	﹤0.01%	1243
2015 Q3	$4.51M	Buy	309,700 +34,700	+13%	+$581K	﹤0.01%	1165
2015 Q2	$4.58M	Hold	275,000	–	–	﹤0.01%	1190
2015 Q1	$6.02M	Hold	275,000	–	–	﹤0.01%	1151
2014 Q4	$5.96M	Hold	275,000	–	–	﹤0.01%	1161
2014 Q3	$4.73M	Buy	+275,000	New	+$4.41M	﹤0.01%	1192

Other funds holding PRQR

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PVI

Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JGC

J. Goldman & Co New York $3.87B AUM 46.92% 1-Year Est. Return

Franklin Resources's PRQR Position: Q2 2018 in Review

Franklin Resources sold out of ProQR Therapeutics (PRQR) in Q2 2018, closing a stake of 309,700 shares — an estimated $952K sold.

Franklin Resources first reported a position in PRQR in Q3 2014 and held it in 15 quarters. The position peaked at $6.02M in Q1 2015. 25 funds tracked by Wall St. Rank hold PRQR as of Q2 2018.

Franklin Resources reported no remaining ProQR Therapeutics position as of Q2 2018 after selling out during the quarter.
Franklin Resources sold 309,700 ProQR Therapeutics shares in Q2 2018, an estimated $952K.
Franklin Resources first reported a position in ProQR Therapeutics in Q3 2014 and held it in 15 quarters.
Franklin Resources's ProQR Therapeutics position peaked at $6.02M in Q1 2015.
25 funds tracked by Wall St. Rank held ProQR Therapeutics as of Q2 2018.

Based on Franklin Resources's 13F filing for Q2 2018, filed 14 Aug 2018.